
Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
iGan Partners is a venture capital firm based in Toronto, Canada, established to support entrepreneurs innovating in the healthcare sector. Founded with a mission to invest in technological advancements in healthcare, the firm has built a reputation for backing companies that enhance healthcare delivery and outcomes. iGan Partners primarily focuses on Seed to Series A stage investments, providing follow-on funding until exit.
The firm operates from its office located at 60 Bloor Street West, 15th Floor, Toronto, ON M4W 3B8. iGan Partners has a notable portfolio of companies and is committed to fostering innovation in healthcare through strategic investments. While specific metrics such as total assets under management (AUM) are not disclosed, the firm is recognized for its active involvement in supporting its portfolio companies.
iGan Partners invests in companies at the Seed to Series A stages, emphasizing disruptive sectors such as AI-enabled MedTech and Digital Health. The firm seeks to back innovations that significantly improve healthcare outcomes and reduce costs. Their investment strategy includes providing follow-on funding to portfolio companies until exit, ensuring ongoing support throughout the investment lifecycle.
iGan Partners looks for entrepreneurs who are developing solutions that enhance healthcare delivery. The firm values technological advancements that can lead to better patient outcomes and cost efficiencies in the healthcare system. Their geographic focus is primarily on North America, particularly Canada, aligning with their commitment to supporting local innovation.
iGan Partners has a diverse portfolio of notable companies in the healthcare sector, including:
Sam Ifergan: Founder & Managing Partner. Sam has extensive experience in venture capital and healthcare investments, having led numerous successful funding rounds.
Dr. Lorena Tora: Chief Medical Officer. Dr. Tora brings a wealth of medical expertise and insights into healthcare innovations, guiding investment decisions.
Billy Lai: Venture Partner. Billy has a strong background in technology and healthcare, focusing on identifying promising startups.
Wendi Zhao: Director, Investment & Portfolio Management. Wendi oversees portfolio management and supports companies in achieving their growth objectives.
Anita Nunes: HR Office Manager. Anita manages human resources and organizational development within the firm.
David Ifergan: Investment and Operations Analyst. David supports investment analysis and operational efficiency across the portfolio.
Joel Finlayson: Venture Partner. Joel has a background in healthcare investments and works closely with portfolio companies to drive growth.
To pitch to iGan Partners, founders should send an email to info@iganpartners.com. It is recommended to include a concise pitch deck that outlines the business model, market opportunity, and team background. A clear articulation of the problem being addressed and the solution offered is essential.
iGan Partners has been actively supporting its portfolio companies, with notable investments in Cosm Medical, Exact Imaging, MolecuLight, and Flosonics Medical. The firm continues to emphasize its commitment to fostering healthcare innovation through ongoing support and follow-on funding.
Recent activities include participation in various funding rounds for its portfolio companies, showcasing their dedication to enhancing healthcare delivery and outcomes through technological advancements.
What are iGan Partners' investment criteria?
iGan Partners focuses on Seed to Series A stage companies, particularly in the healthcare sector. They look for innovations in AI-enabled MedTech and Digital Health that can significantly improve healthcare outcomes and reduce costs.
How can I apply or pitch to iGan Partners?
Founders can pitch to iGan Partners by sending an email to info@iganpartners.com. It is advisable to include a detailed overview of the business, the problem it addresses, and how it plans to achieve its goals.
What makes iGan Partners different from other venture capital firms?
iGan Partners emphasizes ongoing support through follow-on funding until exit, showcasing their commitment to the success of their portfolio companies. They focus specifically on healthcare innovations, which allows them to provide specialized insights and resources.
What is the geographic scope of iGan Partners' investments?
The firm primarily invests in North America, with a strong focus on Canadian companies. This geographic focus allows them to support local entrepreneurs and innovations.
What is the typical check size for investments?
While specific check sizes are not disclosed, iGan Partners invests in Seed to Series A stages, which typically involves initial investments that can range from hundreds of thousands to several million dollars, depending on the company’s needs and growth potential.
What kind of post-investment involvement does iGan Partners have?
iGan Partners maintains active involvement with its portfolio companies, providing ongoing support and follow-on funding as needed. They work closely with founders to help navigate challenges and capitalize on growth opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.